June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The Influence of Plasmalemma Vesicle-Associated Protein on Conventional Outflow Facility in Mice
Author Affiliations & Notes
  • Ester Reina-Torres
    Bioengineering, Imperial College London, London, United Kingdom
  • Leonie Herrnberger
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Joseph M Sherwood
    Bioengineering, Imperial College London, London, United Kingdom
  • Ernst R Tamm
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Darryl R Overby
    Bioengineering, Imperial College London, London, United Kingdom
  • Footnotes
    Commercial Relationships Ester Reina-Torres, None; Leonie Herrnberger, None; Joseph Sherwood, None; Ernst Tamm, None; Darryl Overby, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3543. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ester Reina-Torres, Leonie Herrnberger, Joseph M Sherwood, Ernst R Tamm, Darryl R Overby; The Influence of Plasmalemma Vesicle-Associated Protein on Conventional Outflow Facility in Mice. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3543.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Plasmalemma Vesicle-Associated Protein (PLVAP) is necessary for fenestra formation in fenestrated endothelia. Schlemm’s canal (SC) has fenestra-like mini-pores of 60-80nm, and fewer SC mini-pores are observed in mice lacking PLVAP. As mini-pores may be precursors of micron-sized intracellular pores in SC endothelium, we hypothesize that PLVAP plays a role in modulating conventional outflow facility (C). We investigate the effect of PLVAP depletion on IOP and outflow facility, and additionally examine how C is affected by the actin-disrupting drug latrunculin B.

Methods: This project used wild type (WT: PLVAP+/+) and knock-down (KD: PLVAP-/+) mouse littermates, 9-12 weeks of age, on a C57/BL/N background. Both genders were used. IOP was measured by rebound tonometry on anesthetized mice. C was measured in enucleated eyes using the iPerfusion system optimized for mouse eyes. When evaluating the difference between WT and KD, one eye of each mouse was perfused with DBG (Dulbecco’s PBS + 5.5mM glucose). To assess the effect of latrunculin B in WT and KD, one eye was perfused with 1µM latrunculin B in DBG while the contralateral eye was perfused with DBG + vehicle. Statistical significance was determined by a customized weighted t-test.

Results: The WT and KD mice had similar IOP at 11 weeks, 12.8 ± 2.2 mmHg (mean ± SD, n = 14) and 12.8 ±1.5 mmHg (n = 12) respectively. However, C was reduced by 31% in KD versus WT (p = 0.06; n = 14 KD; n = 12 WT). Eyes from WT mice perfused with 1µM latrunculin B had 25% higher C (p < 0.02; n = 7 pairs) relative to contralateral controls, whereas KD mice experienced a 62% increase (p < 0.0001; n = 7 pairs). There was no significant difference between eyes from WT and KD mice treated with latrunculin B (p > 0.9).

Conclusions: Facility was reduced in PLVAP-depleted mice, suggesting that PLVAP-containing mini-pores may contribute to outflow regulation. However, IOP was unaffected, possibly because fenestrae are necessary for aqueous humor production by ciliary process capillaries. Cytoskeletal disruption by latrunculin eliminated the influence of PLVAP, suggesting a cellular origin for the extra resistance in the PLVAP-depleted mice. Electron microscopy studies are necessary to examine the role of PLVAP in pore formation in SC.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×